These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 8149346

  • 1. Expression of plasminogen activator inhibitor type 1 (PAI-1) by HT-29di human large bowel carcinoma cells is modulated as a function of epithelial differentiation.
    Higgins PJ, Lipkin M.
    Cancer Lett; 1994 Jan 30; 76(2-3):167-75. PubMed ID: 8149346
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
    Yoshida M, Tanaka Y, Eguchi T, Ikekawa N, Saijo N.
    Anticancer Res; 1992 Jan 30; 12(6B):1947-52. PubMed ID: 1363510
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells.
    Dong-Le Bourhis X, Lambrecht V, Boilly B.
    Br J Cancer; 1998 Jan 30; 77(3):396-403. PubMed ID: 9472634
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. p52(PAI-1) and actin expression in butyrate-induced flat revertants of v-ras-transformed rat kidney cells.
    Higgins PJ, Ryan MP.
    Biochem J; 1991 Nov 01; 279 ( Pt 3)(Pt 3):883-90. PubMed ID: 1953684
    [Abstract] [Full Text] [Related]

  • 11. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
    Yang GY, Shamsuddin AM.
    Anticancer Res; 1995 Nov 01; 15(6B):2479-87. PubMed ID: 8669811
    [Abstract] [Full Text] [Related]

  • 12. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells.
    Antalis TM, Reeder JA.
    Int J Cancer; 1995 Sep 04; 62(5):619-26. PubMed ID: 7665235
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.
    Gross JL, Behrens DL, Mullins DE, Kornblith PL, Dexter DL.
    Cancer Res; 1988 Jan 15; 48(2):291-6. PubMed ID: 3121170
    [Abstract] [Full Text] [Related]

  • 14. Butyrate-induced alterations of phosphoinositide metabolism, protein kinase C activity and reduced CD44 variant expression in HT-29 colon cancer cells.
    Kopp R, Fichter M, Assert R, Pfeiffer AF, Classen S.
    Int J Mol Med; 2009 May 15; 23(5):639-49. PubMed ID: 19360323
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells.
    Krupitza G, Grill S, Harant H, Hulla W, Szekeres T, Huber H, Dittrich C.
    Br J Cancer; 1996 Feb 15; 73(4):433-8. PubMed ID: 8595156
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation.
    Kjøller L, Kanse SM, Kirkegaard T, Rodenburg KW, Rønne E, Goodman SL, Preissner KT, Ossowski L, Andreasen PA.
    Exp Cell Res; 1997 May 01; 232(2):420-9. PubMed ID: 9168821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.